[PDF][PDF] Evaluation of Interleukin-33, Interleukin-10 Levels in Rheumatoid Arthritis Patients on Long Term Therapy of Disease-Modifying Antirheumatic Drugs
AM Azeez, IAA Dheep - SAR J Pathol Microbiol, 2024 - sarpublication.com
Background: Rheumatoid arthritis is a prevalent, long-term, inflammatory autoimmune
illness with a wide range of extra-articular symptoms that affects 0.24% of people worldwide …
illness with a wide range of extra-articular symptoms that affects 0.24% of people worldwide …